\-\ Texto\\:\\ \ \(0\)\
\-\ diffuse\\ expiratory\\ wheezing\ \(0\)\
\-\ \\â\\€\\¢\\ bronchodilators\ \(1\)\
\-\ \\â\\€\\¢\\ steroids\ \(1\)\
\-\ hyperinflated\\ lungs\\ with\\ flattening\\ of\\ hemidiaphragms\\ and\\ increased\\ ap\\ diameter\ \(0\)\
\-\ asthma\\ with\\ air\\ trapping\ \(0\)\
\-\ \\â\\€\\¢\\ reactive\\ airway\\ disease\\ \\(asthma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ viral\\ illness\\ with\\ diffuse\\ air\\ trapping\ \(0\)\
\-\ wheezing\\,\\ no\\ fever\ \(0\)\
\-\ \\â\\€\\¢\\ reactive\\ airway\\ disease\\ and\\ viral\\ illness\\ can\\ have\\ similar\\ features\\ to\\ include\\ bronchial\\ wall\\ thickening\\ \\(cuffing\\ and\\ tram\\-tracks\\)\\,\\ hyperinflation\\ from\\ air\\ trapping\\ \\(partial\\ bronchial\\ obstruction\\)\\,\\ and\\ atelectasis\\ \\(areas\\ of\\ complete\\ bronchial\\ obstruction\\;\\ ie\\:\\ mucous\\ plugging\\)\ \(0\)\
\-\ \\â\\€\\¢\\ airblock\\ phenomena\\ are\\ more\\ likely\\ in\\ asthmatic\\ patients\\,\\ to\\ include\\ pneumomediastinum\\ and\\ pneumothorax\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trapping\\:\\ 0\\.16672265657835048\ \(0\)\
\-\ bronchial\\:\\ 0\\.1453567953124313\ \(0\)\
\-\ wheezing\\:\\ 0\\.09888634826117215\ \(0\)\
\-\ airway\\:\\ 0\\.09510150826840158\ \(0\)\
\-\ illness\\:\\ 0\\.09510150826840158\ \(0\)\
\-\ asthma\\:\\ 0\\.09442347723488796\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.09402086109575326\ \(0\)\
\-\ tram\\-tracks\\:\\ 0\\.08815518423966498\ \(0\)\
\-\ airblock\\:\\ 0\\.08815518423966498\ \(0\)\
\-\ air\\:\\ 0\\.08673787879655898\ \(0\)\
\-\ viral\\:\\ 0\\.08609317834899298\ \(0\)\
\-\ reactive\\:\\ 0\\.08089667599001667\ \(0\)\
\-\ bronchodilators\\:\\ 0\\.07716906135298389\ \(0\)\
\-\ asthmatic\\:\\ 0\\.07429224062846608\ \(0\)\
\-\ hyperinflated\\:\\ 0\\.06736076882286662\ \(0\)\
\-\ cuffing\\:\\ 0\\.06736076882286662\ \(0\)\
\-\ hemidiaphragms\\:\\ 0\\.06618293846630278\ \(0\)\
\-\ phenomena\\:\\ 0\\.06330611774178498\ \(0\)\
\-\ expiratory\\:\\ 0\\.06107468222864288\ \(0\)\
\-\ plugging\\:\\ 0\\.06042929701726717\ \(0\)\
\-\ obstruction\\:\\ 0\\.06026800097178871\ \(0\)\
\-\ hyperinflation\\:\\ 0\\.05819786150412507\ \(0\)\
\-\ ie\\:\\ 0\\.05557421885945016\ \(0\)\
\-\ pneumomediastinum\\:\\ 0\\.053190108625000176\ \(0\)\
\-\ diffuse\\:\\ 0\\.0517401484075063\ \(0\)\
\-\ mucous\\:\\ 0\\.049236981258558715\ \(0\)\
\-\ include\\:\\ 0\\.047943069760605736\ \(0\)\
\-\ flattening\\:\\ 0\\.04656635340606826\ \(0\)\
\-\ atelectasis\\:\\ 0\\.041059882226541645\ \(0\)\
\-\ steroids\\:\\ 0\\.04019727878369757\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.04011497379233241\ \(0\)\
\-\ features\\:\\ 0\\.03606032271125077\ \(0\)\
\-\ diameter\\:\\ 0\\.035951625988881734\ \(0\)\
\-\ partial\\:\\ 0\\.03417355722448746\ \(0\)\
\-\ similar\\:\\ 0\\.033516866189408884\ \(0\)\
\-\ lungs\\:\\ 0\\.032357885979802756\ \(0\)\
\-\ ap\\:\\ 0\\.03125158969642438\ \(0\)\
\-\ complete\\:\\ 0\\.030073759339860544\ \(0\)\
\-\ thickening\\:\\ 0\\.028966245696933516\ \(0\)\
\-\ fever\\:\\ 0\\.028912626265519662\ \(0\)\
\-\ \\(\\:\\ 0\\.028894469049754422\ \(0\)\
\-\ areas\\:\\ 0\\.02875347171246067\ \(0\)\
\-\ \\)\\:\\ 0\\.028541507684532202\ \(0\)\
\-\ disease\\:\\ 0\\.027934750824314084\ \(0\)\
\-\ wall\\:\\ 0\\.02475159120238746\ \(0\)\
\-\ likely\\:\\ 0\\.024102899659356566\ \(0\)\
\-\ patients\\:\\ 0\\.022115745993660257\ \(0\)\
\-\ more\\:\\ 0\\.02137176309312166\ \(0\)\
\-\ increased\\:\\ 0\\.020904847817996557\ \(0\)\
\-\ \\;\\:\\ 0\\.020254211884525936\ \(0\)\
\-\ can\\:\\ 0\\.019382223524690698\ \(0\)\
\-\ have\\:\\ 0\\.01850438078365092\ \(0\)\
\-\ from\\:\\ 0\\.012664357131542124\ \(0\)\
\-\ are\\:\\ 0\\.011648738725296018\ \(0\)\
\-\ \\:\\:\\ 0\\.01130274815990665\ \(0\)\
\-\ \\,\\:\\ 0\\.010828402620691496\ \(0\)\
\-\ and\\:\\ 0\\.009000450286610923\ \(0\)\
\-\ no\\:\\ 0\\.00860444150703802\ \(0\)\
\-\ to\\:\\ 0\\.008541362168859725\ \(0\)\
\-\ in\\:\\ 0\\.0042139723014025495\ \(0\)\
\-\ with\\:\\ 0\\.003510125282696692\ \(0\)\
\-\ of\\:\\ 0\\.0023300760159597686\ \(0\)\
